| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Laboratories of
*
Viral Diseases and
Immunology, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892; and
Mount Sinai School of Medicine of City University of New York, Department of Pharmacology, New York, NY 10029
To study the role of proteasomes in Ag presentation, we analyzed the effects of proteasome inhibitors Cbz-Leu-Leu-Leucinal and lactacystin on the ability of mouse fibroblast cells to present recombinant vaccinia virus gene products to MHC class I-restricted T cells. The effects of the inhibitors depended on the determinant analyzed. For influenza virus nucleoprotein (NP), presentation of the immunodominant Kk-restricted determinant (NP50–57) was marginally inhibited, whereas presentation of the immunodominant Kd-restricted determinant (NP147–155) was enhanced, particularly by lactacystin. Biochemical purification of peptides confirmed that lactacystin enhanced the generation of Kd-NP147–155 complexes fourfold. Lactacystin also enhanced the recovery of one Kd-restricted vaccinia virus determinant from HPLC fractions, while inhibiting recovery of another. The inhibitors were used at sufficient concentrations to block presentation of biosynthesized full-length OVA and to completely stabilize a rapidly degraded chimeric ubiquitin-NP fusion protein. Strikingly, presentation of antigenic peptides from this protein was unaffected by proteasome inhibitors. We also observed that proteasome inhibitors induced expression of cytosolic and endoplasmic reticulum stress-responsive proteins. These data demonstrate first that the processes of protein degradation and generation of antigenic peptides from cytosolic proteins can be dissociated, and second that effects of proteasome inhibitors on Ag presentation may reflect secondary effects on cellular metabolism.
This article has been cited by other articles:
|
|
 |
|
  M. Basler, C. Lauer, U. Beck, and M. Groettrup The Proteasome Inhibitor Bortezomib Enhances the Susceptibility to Viral Infection J. Immunol., November 15, 2009; 183(10): 6145 - 6150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Smith, N. Wakisaka, T. Crough, J. Peet, T. Yoshizaki, L. Beagley, and R. Khanna Discerning regulation of cis- and trans-presentation of CD8+ T-cell epitopes by EBV-encoded oncogene LMP-1 through self-aggregation Blood, June 11, 2009; 113(24): 6148 - 6152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Goldwich, S. S. C. Hahn, S. Schreiber, S. Meier, E. Kampgen, R. Wagner, M. B. Lutz, and U. Schubert Targeting HIV-1 Gag into the Defective Ribosomal Product Pathway Enhances MHC Class I Antigen Presentation and CD8+ T Cell Activation J. Immunol., January 1, 2008; 180(1): 372 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Marcilla, J. J. Cragnolini, and J. A. Lopez de Castro Proteasome-independent HLA-B27 Ligands Arise Mainly from Small Basic Proteins Mol. Cell. Proteomics, May 1, 2007; 6(5): 923 - 938. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Guil, M. Rodriguez-Castro, F. Aguilar, E. M. Villasevil, L. C. Anton, and M. Del Val Need for Tripeptidyl-peptidase II in Major Histocompatibility Complex Class I Viral Antigen Processing when Proteasomes are Detrimental J. Biol. Chem., December 29, 2006; 281(52): 39925 - 39934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Wherry, T. N. Golovina, S. E. Morrison, G. Sinnathamby, M. J. McElhaugh, D. C. Shockey, and L. C. Eisenlohr Re-evaluating the Generation of a "Proteasome-Independent" MHC Class I-Restricted CD8 T Cell Epitope J. Immunol., February 15, 2006; 176(4): 2249 - 2261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. N. Golovina, S. E. Morrison, and L. C. Eisenlohr The Impact of Misfolding versus Targeted Degradation on the Efficiency of the MHC Class I-Restricted Antigen Processing J. Immunol., March 1, 2005; 174(5): 2763 - 2769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Reed, B. Berwin, J. P. Baker, and C. V. Nicchitta GRP94/gp96 Elicits ERK Activation in Murine Macrophages: A ROLE FOR ENDOTOXIN CONTAMINATION IN NF-{kappa}B ACTIVATION AND NITRIC OXIDE PRODUCTION J. Biol. Chem., August 22, 2003; 278(34): 31853 - 31860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lomas, E. Hanon, Y. Tanaka, C. R. M. Bangham, and K. G. Gould Presentation of a new H-2Dk-restricted epitope in the Tax protein of human T-lymphotropic virus type I is enhanced by the proteasome inhibitor lactacystin J. Gen. Virol., March 1, 2002; 83(3): 641 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ota, T. Ono, A. Morita, A. Uenaka, M. Harada, and E. Nakayama Cellular Processing of a Multibranched Lysine Core with Tumor Antigen Peptides and Presentation of Peptide Epitopes Recognized by Cytotoxic T Lymphocytes on Antigen-presenting Cells Cancer Res., March 1, 2002; 62(5): 1471 - 1476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Norbury, M. F. Princiotta, I. Bacik, R. R. Brutkiewicz, P. Wood, T. Elliott, J. R. Bennink, and J. W. Yewdell Multiple Antigen-Specific Processing Pathways for Activating Naive CD8+ T Cells In Vivo J. Immunol., April 1, 2001; 166(7): 4355 - 4362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yewdell, U Schubert, and J. Bennink At the crossroads of cell biology and immunology: DRiPs and other sources of peptide ligands for MHC class I molecules J. Cell Sci., January 3, 2001; 114(5): 845 - 851. [Abstract] [PDF]
|
|
|
|
|
|
N. A. Marshall, J. G. Howe, R. Formica, D. Krause, J. E. Wagner, N. Berliner, J. Crouch, I. Pilip, D. Cooper, B. R. Blazar, et al. Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation Blood, October 15, 2000; 96(8): 2814 - 2821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hudrisier, J. Riond, H. Mazarguil, M. B. A. Oldstone, and J. E. Gairin Genetically Encoded and Post-translationally Modified Forms of a Major Histocompatibility Complex Class I-restricted Antigen Bearing a Glycosylation Motif Are Independently Processed and Co-presented to Cytotoxic T Lymphocytes J. Biol. Chem., December 17, 1999; 274(51): 36274 - 36280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Y. Mo, P. Cascio, K. Lemerise, A. L. Goldberg, and K. Rock Distinct Proteolytic Processes Generate the C and N Termini of MHC Class I-Binding Peptides J. Immunol., December 1, 1999; 163(11): 5851 - 5859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Gileadi, H. T. Moins-Teisserenc, I. Correa, B. L. Booth Jr., P. R. Dunbar, A. K. Sewell, J. Trowsdale, R. E. Phillips, and V. Cerundolo Generation of an Immunodominant CTL Epitope Is Affected by Proteasome Subunit Composition and Stability of the Antigenic Protein J. Immunol., December 1, 1999; 163(11): 6045 - 6052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. P. Papadopoulos, C. S. Hesdorffer, N. Suciu-Foca, H. Hibshoosh, and P. E. Harris Wild-Type p53 Epitope Naturally Processed and Presented by an HLA-B Haplotype on Human Breast Carcinoma Cells Clin. Cancer Res., August 1, 1999; 5(8): 2089 - 2093. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Anton, U. Schubert, I. Bacik, M. F. Princiotta, P. A. Wearsch, J. Gibbs, P. M. Day, C. Realini, M. C. Rechsteiner, J. R. Bennink, et al. Intracellular Localization of Proteasomal Degradation of a Viral Antigen J. Cell Biol., July 12, 1999; 146(1): 113 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Sewell, D. A. Price, H. Teisserenc, B. L. Booth Jr., U. Gileadi, F. M. Flavin, J. Trowsdale, R. E. Phillips, and V. Cerundolo IFN-{gamma} Exposes a Cryptic Cytotoxic T Lymphocyte Epitope in HIV-1 Reverse Transcriptase J. Immunol., June 15, 1999; 162(12): 7075 - 7079. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Valmori, U. Gileadi, C. Servis, P. R. Dunbar, J.-C. Cerottini, P. Romero, V. Cerundolo, and F. Levy Modulation of Proteasomal Activity Required for the Generation of a Cytotoxic T Lymphocyte-defined Peptide Derived from the Tumor Antigen MAGE-3 J. Exp. Med., March 15, 1999; 189(6): 895 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Andre, M. Groettrup, P. Klenerman, R. de Giuli, B. L. Booth Jr., V. Cerundolo, M. Bonneville, F. Jotereau, R. M. Zinkernagel, and V. Lotteau An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses PNAS, October 27, 1998; 95(22): 13120 - 13124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. P. N. Emmerich, A. K. Nussbaum, S. Stevanovic, M. Priemer, R. E. M. Toes, H.-G. Rammensee, and H. Schild The Human 26 S and 20 S Proteasomes Generate Overlapping but Different Sets of Peptide Fragments from a Model Protein Substrate J. Biol. Chem., July 7, 2000; 275(28): 21140 - 21148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Komlosh, F. Momburg, T. Weinschenk, N. Emmerich, H. Schild, E. Nadav, I. Shaked, and Y. Reiss A Role for a Novel Luminal Endoplasmic Reticulum Aminopeptidase in Final Trimming of 26 S Proteasome-generated Major Histocompatability Complex Class I Antigenic Peptides J. Biol. Chem., August 3, 2001; 276(32): 30050 - 30056. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
